HCM logo

HCM HUTCHMED (China) Limited

NASDAQ Global Select · Drug Manufacturers - Specialty & Generic · Healthcare

$14.40
-0.33 (-2.24%)

HUTCHMED (China) Limited is a biopharmaceutical firm dedicated to the discovery, advancement, and marketing of innovative targeted and immune-based treatments for various cancers and immune-related disorders. Its operations are divided into two main areas: Oncology/Immunology and a segment encompassing Other Ventures. The company's reach extends from Hong Kong globally. Among its pipeline, HUTCHME…

Market Cap: $2.51Bwww.hutch-med.com

Price

No data yet.

Social Signal Score

45
5d
50
2 mentions
—
30d
42
10 mentions
—
60d
46
15 mentions
—
90d
43
23 mentions
—
news: 23

Analyst Ratings

10 analysts
Buyconsensus
Strong Buy 0Buy 8Hold 1Sell 1Strong Sell 0
Avg price target$22.78+58.2%
Low $13.6Median $16.25High $45
Current Consensus

Revenue

$139.14M+149.44%
$49.08M$121.53M$193.99M$266.44M
Sep 2016Jun 2026

Analyst Estimates

FY2025
$2.69
$1.95–$3.24
4 analysts
FY2026
$0.38-86% YoY
$0.03–$0.59
4 analysts
FY2027
$0.48+28% YoY
$0.22–$0.68
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Chig Fung Cheng
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,796
Beta
0.43
Country
HK
Piotroski score
6 / 9 (Middling)
Altman Z-score
4.18
www.hutch-med.com